Bramhall, United Kingdom

Philip N Edwards



 

Average Co-Inventor Count = 2.5

ph-index = 15

Forward Citations = 477(Granted Patents)

Forward Citations (Not Self Cited) = 420(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Macclesfield, EN (1976)
  • Stockport, GB (1982 - 1999)
  • Cheshire, GB (1992 - 2001)
  • Macclesfield, GB (1979 - 2003)
  • Bramhall, GB (1982 - 2013)

Company Filing History:


Years Active: 1976-2013

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antifungal Agents
Peptide Derivatives
Phenanthroline Derivatives
5-Lipoxygenase Inhibitors
Heterocyclic Derivatives
Quinoxalinyl Derivatives
Phenol Derivatives
Diaryl Ether Compounds
Thiazole Inhibitors
Histamine H2-Antagonists
Oxime Derivatives
Haloguanidine Compounds
52 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Philip N Edwards based on the provided data:

Title: Innovator Spotlight - Philip N Edwards: Pioneering Inventions in the Pharmaceutical Industry

Introduction:

Philip N Edwards, a seasoned inventor hailing from Bramhall, GB, is a prominent figure in the field of pharmaceutical innovations. With an impressive portfolio of 52 patents, his groundbreaking work has significantly contributed to advancements in antifungal agents and peptide derivatives.

Latest Patents:

Among his latest patents, Philip N Edwards has introduced novel antifungal agents that exhibit promising therapeutic potential. These compounds, characterized by their chemical formula (I), have applications as potent antifungal agents and agriculturally acceptable fungicides. Additionally, his research in peptide derivatives has led to the development of pharmaceutical compositions effective in treating autoimmune and inflammatory diseases, particularly targeting MHC class II dependent T-cell methods like rheumatoid arthritis.

Career Highlights:

Throughout his illustrious career, Philip N Edwards has been associated with renowned companies such as Imperial Chemical Industries Limited (ICI) and ICI Pharma. His tenure at these organizations has been marked by groundbreaking research, innovative discoveries, and a commitment to pushing the boundaries of pharmaceutical science.

Collaborations:

In his collaborative endeavors, Philip N Edwards has had the privilege of working alongside esteemed professionals in the field. Notable coworkers include Michael S Large and Graham C Crawley, with whom he has synergized efforts to drive innovation and bring transformative solutions to the forefront of the pharmaceutical industry.

Conclusion:

In conclusion, Philip N Edwards stands as a distinguished inventor whose relentless pursuit of innovation has paved the way for significant breakthroughs in pharmaceutical research. His pioneering work in antifungal agents and peptide derivatives serves as a testament to his exceptional expertise and unwavering dedication to advancing science for the betterment of society.

Should you require further information or details on Philip N Edwards's inventions and patents, feel free to explore our website for comprehensive insights into his remarkable contributions to the world of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…